Press-room / Digest

Autophagy activator with AMPK-mediated mechanism of action
Age-related imbalance between synthesis and degradation of biomolecules in cells leads to the development of, among other, neurodegenerative diseases and diabetes. A decrease in autophagy, a process that is involved in degradation of damaged or dysfunctional cellular components, may contribute to this imbalance. Autophagy is regulated within cells through multiple signaling pathways, including the AMPK (AMP-activated protein kinase)-dependent pathway, which functions as a key sensor of changes in the cell's energy status. Researchers from the IBCh RAS, the A.N. Belozersky Institute of Physicochemical Biology of Moscow State University, the Patrice Lumumba Peoples' Friendship University of Russia, and other institutes assessed the ability of phenoxazine derivatives to activate this process. The lead compound demonstrated specific activation via the AMPK-dependent pathway and low cytotoxicity in three non-cancer cell lines. The work was published in Bioorganic Chemistry.

Plasma protein corona of liposomes loaded with a phospholipid–allocolchicinoid conjugate enhances their anti-inflammatory potential
The staff of the Laboratory of Lipid Chemistry IBCh RAS, together with colleagues from Nizhny Novgorod State University and the Human Proteome Center of the Institute of Biomedical Chemistry, studied the effects of protein coronas formed in human blood plasma ex vivo on different liposomes carrying a colchicine analog. Today colchicine is considered as a possible treatment for cardiovascular complications. On a model of monocytes from human peripheral blood, the protein coronas have been shown to enhance the anti-inflammatory potential of liposomes. A particularly sharp effect was observed for liposomes bearing specific proteins, including minor ones in normal plasma. The results are published in Colloids and Surfaces B: Biointerfaces. Learn more

TLR2 and Zinc: A Surprising Partnership in Immune Signaling
A team of scientists from the Laboratory of Biomolecular NMR Spectroscopy at the Institute of Bioorganic Chemistry of the Russian Academy of Sciences, in collaboration with researchers from China, has made a breakthrough in understanding the function of Toll-like receptor 2 (TLR2), a key component of the innate immune system. Their study, published in FEBS Letters, reveals that TLR2 exhibits a previously unknown ability to bind zinc ions with high affinity and specificity. Toll-like receptors (TLRs) serve as the first line of defense in the immune system by recognizing pathogens and initiating immune responses. Despite extensive research, the precise molecular mechanisms governing TLR activation remain elusive. The newly identified zinc-binding capability of TLR2 provides fresh insights into its regulatory mechanisms. The researchers also identified specific amino acids essential for zinc coordination and TLR2 function, highlighting a potential link between zinc homeostasis and immune activation. These findings suggest that zinc plays a critical role in modulating TLR-mediated immune signaling, opening new avenues for research into immune system regulation and potential therapeutic applications. Learn more

Comparative analysis of secreted peptide expression during defense response in angiosperms and spore plants
Small secreted peptides (SSPs) play important role in regulating immune response of plants, however, their evolution remains poorly studied. Researchers from the Laboratory of System Analysis of Proteins and Peptides and the Laboratory of Neuroreceptors and Neuroregulators IBCh RAS, as well as SRI PCM, analyzed transcriptomes of angiosperms and spore plants and compared the expression of genes of known SSPs in response to phytopathogens infection. The role of EPFL, MEG, and PSY peptides in regulating the immune response in both groups of organisms was shown. In addition, previously unknown PSY-like SSPs were discovered in bryophytes and their biological activity was analyzed. The work was supported by the RSF grant No. 23-74-10048 and published in the Physiologia plantarum.

Potent painkiller from spider venom
A whole family of peptides with completely unexpected activity has been discovered in spider venom. These peptides inhibit mammalian purinergic receptors with high affinity and selectivity. A peptide called purotoxin-6 (PT6) from the venom of the crab spider Thomisus onustus inhibits P2X3 receptors, an important pharmacological target in a number of pain syndromes and chronic cough. PT6 has a compact fold and exhibits a potent analgesic effect in animal models of osteoarthritis and trigeminal neuralgia. At the same time, unlike small-molecule P2X3 ligands that are being developed as drugs, purotoxin does not cause dysgeusia, i.e., distortion of the sense of taste. Research on purotoxins began at the Institute of Bioorganic Chemistry some 20 years ago under the supervision of Academician Eugene Grishin and was successfully continued by Alexander Vassilevski. The results, unique on a global scale, were published in Molecular Therapy. Learn more